The Tokyo Stock Exchange-listed biopharma company will release presentation slides before a live investor webcast featuring Chris Cargill, Hironoshin Nomura, Toshi Maeda and Patrik Foerch.
Nxera Pharma Co. Ltd said it will announce its 2Q 2026 earnings results and operational highlights on Friday, 7 August 2026, followed by a live webinar for investors and analysts at 5:00 pm JST, or 9:00 am GMT. The session will feature Chris Cargill, President, CEO, Hironoshin Nomura, CFO, Toshi Maeda, COO, and Patrik Foerch, CSO and President of Nxera Pharma UK, and will include a presentation and Q&A. Slides will be posted through the investor section of the company’s website by 4:30 pm JST, or 8:30 am GMT, the same day. Nxera describes itself as a technology-powered biopharma company focused on specialty medicines for patients with unmet needs in Japan and globally, combining a commercial business in Japan with an internal and partnered pipeline supported by its NxWave GPCR (cell-surface receptor family) structure-based drug discovery platform.